LUCD - Lucid Diagnostics Inc

https://www.luciddx.com

Buy Momentum: Bearish

Recent News

Lucid Diagnostics Inc. ( LUCD ) Reports Q2 Loss, Tops Revenue Estimates

Zacks Commentary • 1 month ago • score: 0.14

Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -11.11% and +29.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Bullish

Lucid Diagnostics Inc. ( LUCD ) Reports Q1 Loss, Lags Revenue Estimates

Zacks Commentary • 4 months ago • score: 0.18

Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -77.78% and 36.31%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.

52W High

$1.80

52W Low

$0.73

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.25

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.68

EV/Revenue (<3 favorable)

43.68

P/S (TTM) (<3 favorable)

32.02

P/B (<3 favorable)

2.16

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

34.55%

Institutions (25–75% balanced)

18.87%

Shares Outstanding

101,893,000

Float

64,584,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

4,360,000

Gross Profit (TTM)

-2,584,000

EPS (TTM)

-0.95

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-9.79%

ROE (TTM) (>15% strong)

-4.64%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.19

Momentum

Bearish momentum

Value

0.0101

0.0286

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025